AAP
AUGX

Ardsley Advisory Partners’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Ardsley Advisory Partners’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-525,000
Closed -$2.15M – 187
2024
Q1 		$2.15M Hold
525,000
– – 0.31% 69
2023
Q4 		$3.07M Buy
+525,000
New +$2.76M 0.47% 53

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Ardsley Advisory Partners's AUGX Position: Q2 2024 in Review

Ardsley Advisory Partners sold out of Augmedix, Inc. Common Stock (AUGX) in Q2 2024, closing a stake of 525,000 shares — an estimated $2.15M sold.

Ardsley Advisory Partners first reported a position in AUGX in Q4 2023 and held it in 2 quarters. The position peaked at $3.07M in Q4 2023. 52 funds tracked by Wall St. Rank hold AUGX as of Q2 2024.

  • Ardsley Advisory Partners reported no remaining Augmedix, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ardsley Advisory Partners sold 525,000 Augmedix, Inc. Common Stock shares in Q2 2024, an estimated $2.15M.
  • Ardsley Advisory Partners first reported a position in Augmedix, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • Ardsley Advisory Partners's Augmedix, Inc. Common Stock position peaked at $3.07M in Q4 2023.
  • 52 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q2 2024.

Based on Ardsley Advisory Partners's 13F filing for Q2 2024, filed 14 Aug 2024.